Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS AND CONTINGENCIES (Details Narrative)

v3.24.1.1.u2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Sep. 19, 2023
Nov. 16, 2021
Dec. 31, 2022
Mar. 31, 2024
Dec. 31, 2023
Oct. 17, 2023
Subsidiary, Sale of Stock [Line Items]            
Purchase of additional shares           22,334
Offering price per share       $ 10.97    
Waived deferred underwriting fee     $ 342,975      
Accrued contingent legal costs       $ 10,753,535 $ 6,449,593  
Business combination acquisition related costs $ 7,000,000          
Broken deal discount       $ 87,371    
Retained Earnings [Member]            
Subsidiary, Sale of Stock [Line Items]            
Waived deferred underwriting fee     $ 6,655,361      
Underwriting Agreement [Member]            
Subsidiary, Sale of Stock [Line Items]            
Underwriter cash discount per unit   $ 0.20        
Payment of underwriting commissions   $ 3,999,049        
Deferred fee   $ 0.35        
Deferred underwriting fee   $ 6,998,336        
Over-Allotment Option [Member]            
Subsidiary, Sale of Stock [Line Items]            
Purchase of additional shares   2,495,246   2,625,000    
Offering price per share   $ 10.00        
Proceeds from shares   $ 24,952,460